Marvell Switching Ecosystem for Broadband Networks and Green Datacenters

Marvell (Nasdaq: MRVL), a worldwide leader in integrated silicon solutions, today announced the mass production of its Prestera® CX family of packet processors for broadband switching and datacenters. Hardware and software solutions based on the Prestera CX family are available from several equipment manufacturers and ODMs in the Marvell switching ecosystem including Accton, Aricent, Interface Masters, System Fabric Works, Vadatech and more.

The Prestera CX family is the first commercially available solution to offer up to 48 ports of 10 Gigabit Ethernet (GbE) on a single chip, and the first with multiple ports of 40GbE with line rate throughput.  These packet processors provide 480Gbps full duplex throughput for Carrier Ethernet, including Mac-in-Mac, Multiprotocol Label Switching (MPLS), Virtual Local Area Network (VLAN) Translation and IP Routing and can support up to 128K subscribers with a single device to meet the exponential growth of Internet traffic and massive deployments of high speed optical broadband networks.

The Prestera CX family's reduced XAUI (RXAUI) interface enables doubling of the switching capacity for current broadband access platforms while maintaining compatibility for legacy line cards, enabling in-field upgrade of access platforms as networks migrate to GPON and 10G EPON.

For Converged Enhanced Ethernet (CEE) networks in next generation datacenter deployments, the Prestera CX family offers a highly differentiated feature set including the industry's first commercially available 40GbE ports, Priority Flow Control and Fiber Channel over Ethernet (FCoE) capabilities including Fiber Channel Awareness and Fiber Channel Forwarding.

Multiple reference designs based on Prestera CX are available from Marvell, pre-loaded with software for enterprise and datacenter switching.  These include a single rack unit 48 port 10G SFP+ solution as well as a modular 40 port 10G SFP+ solution with two ports of 40GbE uplinks.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.